Smarter Utility

 

TMCNet: ATHX, EVCA, - PennyOmega.com Watch List! for Thursday July 29, 2010

[July 28, 2010]

ATHX, EVCA, - PennyOmega.com Watch List! for Thursday July 29, 2010

__ ATHX, Athersys, Inc.

ATHX, a biopharmaceutical company, engages in the discovery and development of therapeutic products in various disease areas in the United States.

ATHX current product development portfolio consists of MultiStem, a patented and proprietary stem cell product that the company is developing as a treatment for multiple disease indications, and that is currently being evaluated in two ongoing clinical trials.


In addition, ATHX is developing novel pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, narcolepsy or other forms of excessive daytime sleepiness.

ATHX's MultiStem is a biologic product that is manufactured from human stem cells obtained from adult bone marrow or other nonembryonic tissue sources.

The product consists of a special class of human stem cells that have the ability to express a range of therapeutically relevant proteins and other factors, as well as form multiple cell types.

Factors expressed by ATHX's MultiStem have the potential to deliver a therapeutic benefit in several ways, such as the reduction of inflammation, protection of damaged or injured tissue, and the formation of new blood vessels in regions of ischemic injury.

These cells exhibit a drug-like profile in that they act primarily through the production of factors that regulate the immune system, protect damaged or injured cells, promote tissue repair and healing and most or all of the cells are cleared from the body over time.

Cells obtained from a single donor require no genetic modification and may be used to produce banks yielding hundreds of thousands to millions of doses of MultiStem - an amount far greater than other stem cell types.

** ATHX reported positive results from its phase I clinical trial of MultiStem, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack.

A heart attack is when blood vessels that supply blood to the heart are blocked, preventing enough oxygen from getting to the heart. The heart muscle dies or becomes permanently damaged.

Heart attacks are the leading cause of death for both men and women worldwide.

The study results, based on four months of post-treatment patient data, demonstrate that ATHX's MultiStem was well tolerated at all dose levels and also suggest improvement in heart function in treated patients.

The phase I clinical trial is an open label, multi-center dose escalation trial evaluating the safety and maximum tolerated dose of a single administration of allogeneic MultiStem cells following an acute myocardial infarction AMI.

More about ATHX at www.athersys.com ************************************************************** EVCA, EVCARCO Inc., EVCA.OB EVCA is the first automotive retail group dedicated to deploying a coast-to-coast network of eco-friendly dealerships and vehicles.

EVCA is bringing to market the most advanced clean technologies available in plug-in electric and alternative fuel vehicles.

EVCA has developed a dealer network allowing growth into most US States by 2012 ** EVCA has officially been granted its four Registered Trademarks including 'EVCARCO' and its slogan 'Future Driven.' TO VIEW THE UNITED STATES PATENT AND TRADEMARK OFFICE WITH SPECIFIC INFORMATION ON EVCARCO CLICK HERE: http://www.uspto.gov/ (Registration number 3,808,447 - Future Driven) (Registration number 3,812,043 - EVCARCO) (Registration number 3,808,446 - EV-CAR-CO) (Registration number 3,808,448 - EV-CAR-CO with logo) EVCA has received significant attention over the last few months with media and press about its range of electric vehicles, business model and its alliances with the Federal Government.

The environment is a global problem. That's why EVCA is looking at areas that need its products the most, when EVCA looks at Mexico City, Mexico with a 28 million population or Lima, Peru, EVCA sees huge requirement for real World Solutions, which is why EVCA is now poised to enter the market.

** EVCA has approved the expansion of its operations into South America. EVCA has appointed Bogota, Colombia as its base of operations for the Texas Corporation.

EVCA plans to introduce the following elements to South America: 1. Government alternative energy advisory 2. Public and commercial electric vehicles 3. Mass transit alternative fuel units 4. All electric taxi and high use units 5. Other viable electric vehicle transportation EVCA has key executives creating alliances with South American governments for long range programs aimed at fossil fuel reduction and adoption of electric vehicles.

More about EVCA at www.evcarco.com ************************************************************** ATHX and EVCA are on PennyOmega.com's RADAR! Do your homework, and like always BE READY for the Action!!! ************************************************************** Sign up to receive FREE stock alerts from PennyOmega.com at http://www.PennyOmega.com/signup ************************************************************** THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings, Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings, Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings, Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings, Inc. (CRWE.OB) has received fifteen thousand dollars in cash and thirty-five thousand EVCARCO, Inc. (EVCA.OB) restricted shares for 30 days of advertising services.

As a community-building service, TMCnet allows user submitted content which is not always proofed by TMCnet editors. If you feel this entry is of inferior quality or wish to report it for some reason, please forward the URL to "webedit [AT] tmcnet [DOT] com" with your comments.


[ Back To Homepage ]